Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients-Reference-Cited by-同舟云学术

Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients

Published:2009-09-10 Issue:14 Volume:23 Page:1829-1840
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

De Meyer Sandra,Lathouwers Erkki,Dierynck Inge,De Paepe Els,Van Baelen Ben,Vangeneugden Tony,Spinosa-Guzman Sabrina,Lefebvre Eric,Picchio Gaston,de Béthune Marie-Pierre

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference24 articles.

1. Treatment for adult HIV infection. 2006 recommendations of the International AIDS Society–USA Panel;Hammer;JAMA,2006

2. The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised noninferiority trial;Eron;Lancet,2006

3. Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patients;Marin-Niebla;Antimicrob Agents Chemother,2007

4. Long-term safety and durable antiretroviral activity of lopinavir/ritonavir in treatment-naive patients: 4 year follow-up study;Hicks;AIDS,2004

5. 96-week comparison of once-daily atazanavir/ritonavir and twice-daily lopinavir/ritonavir in patients with multiple virologic failures;Johnson;AIDS,2006

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genotyping and Antiretroviral Drug Resistance Mutations among HIV Patients in Southern Santa Catarina, Brazil;Current HIV Research;2024-08-13

2. Exploration of imatinib and nilotinib-derived templates as the P2-Ligand for HIV-1 protease inhibitors: Design, synthesis, protein X-ray structural studies, and biological evaluation;European Journal of Medicinal Chemistry;2023-07

3. Evaluation of darunavir-derived HIV-1 protease inhibitors incorporating P2′ amide-derivatives: Synthesis, biological evaluation and structural studies;Bioorganic & Medicinal Chemistry Letters;2023-03

4. Design, Synthesis and X‐Ray Structural Studies of Potent HIV‐1 Protease Inhibitors Containing C‐4 Substituted Tricyclic Hexahydro‐Furofuran Derivatives as P2 Ligands;ChemMedChem;2022-03-04

5. Catalytic Enantioselective Diels Alder Reaction: Application in the Synthesis of Antiviral Agents;Catalysts;2022-01-25